Trademark: 97681398
Word
SOLCO
Status
Registered
Status Code
700
Status Date
Tuesday, March 26, 2024
Serial Number
97681398
Registration Number
7335535
Registration Date
Tuesday, March 26, 2024
Mark Type
4000
Filing Date
Thursday, November 17, 2022
Published for Opposition
Tuesday, January 9, 2024

Trademark Owner History
Prinston Pharmaceutical Inc. - Original Registrant

Classifications
5 Analgesic and muscle relaxant pharmaceutical preparations; antibacterial pharmaceuticals; antimicrobial preservatives for cosmetics and pharmaceuticals; pharmaceutical astringents being astringents for medical purposes; balms for pharmaceutical purposes; cream of tartar for pharmaceutical purposes; creosote for pharmaceutical purposes; dermatological pharmaceutical products; digestives for pharmaceutical purposes; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; ferments for pharmaceutical purposes; inhaled pharmaceutical preparations for the treatment of respiratory disease; injectable pharmaceuticals for treatment of anaphylactic reactions; intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; iodine for pharmaceutical purposes; liquorice for pharmaceutical purposes; menthol for pharmaceutical purposes; pharmaceutical antitussive-cold preparations; pharmaceutical anti-allergic preparations and substances; pharmaceutical for the treatment of erectile dysfunction; pharmaceutical preparations, namely, anticoagulants; pharmaceutical preparations, namely, appetite suppressants; pharmaceutical preparation for the treatment of gout; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical preparations for use in urology; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations, namely, injectable contraceptives; pharmaceutical preparations for treating allergies; pharmaceutical preparations for treating hypertension; pharmaceutical products for treating respiratory disease and asthma; pharmaceutical products for the treatment of joint disease; plant extracts for medical, veterinary and pharmaceutical purposes; potassium preparations for pharmaceutical purposes; pharmaceutical preparations and substances for weight loss; vitamin and mineral supplements for use as ingredients in the food and pharmaceutical industry; drug delivery agents in the form of coatings for pills for facilitating the delivery of a wide range of pharmaceuticals; biological preparations for the treatment of cancer and autoimmune deficiencies and disorders; pharmaceutical, veterinary and sanitary preparations, namely, conjugates of organic and inorganic chemicals with polypeptides, proteins, artificial polypeptides, artificial proteins produced by genetic engineering and for the treatment of viral and infectious diseases, immune system disorders, cancer, diabetes, cardiovascular diseases, central nervous system disorders and diseases; anti-diabetic pharmaceuticals; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; cardiovascular pharmaceuticals; pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; pharmaceutical preparations for treating skin disorders; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer

Trademark Events
Mar 26, 2024
Notice Of Registration Confirmation Emailed
Mar 26, 2024
Registered-Principal Register
Jan 9, 2024
Official Gazette Publication Confirmation E-Mailed
Jan 9, 2024
Published For Opposition
Dec 20, 2023
Notification Of Notice Of Publication E-Mailed
Dec 4, 2023
Approved For Pub - Principal Register
Dec 4, 2023
Teas/Email Correspondence Entered
Dec 4, 2023
Correspondence Received In Law Office
Dec 1, 2023
Teas/Email Correspondence Entered
Dec 1, 2023
Correspondence Received In Law Office
Dec 1, 2023
Teas Response To Office Action Received
Nov 30, 2023
Teas Change Of Correspondence Received
Nov 30, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 30, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Nov 30, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Nov 30, 2023
Teas Change Of Owner Address Received
Sep 7, 2023
Notification Of Non-Final Action E-Mailed
Sep 7, 2023
Non-Final Action E-Mailed
Sep 7, 2023
Non-Final Action Written
Aug 30, 2023
Assigned To Examiner
Dec 8, 2022
New Application Office Supplied Data Entered
Nov 21, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24